Stirlingshire Investments, Inc.

Position in ABBV — AbbVie Inc.

CIK 1829271 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$240,567

+$33,952 QoQ

Shares Held

956

+0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#3,812

of 4,153 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stirlingshire Investments, Inc. holds $1,780,387 across 5 Drug Manufacturers - General names. ABBV ranks #5 (13.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,998	$507,432
2	MRK	Merck & Co., Inc.	2,923	$375,605
3	LLY	ELI LILLY & Co	289	$346,635
4	NVS	Novartis AG	1,979	$310,148
5	ABBV	AbbVie Inc. This page	956	$240,567

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$240,567	956	+0.6%	Shares	Sole	2026-07-31
2026-03-31	$206,615	950	-45.0%	Shares	Sole	2026-05-04
2025-12-31	$394,373	1,726	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.